Treating Disorders of Consciousness With Apomorphine: Protocol for a Double-Blind Randomized Controlled Trial Using Multimodal Assessments

Background: There are few available therapeutic options to promote recovery among patients with chronic disorders of consciousness (DOC). Among pharmacological treatments, apomorphine, a dopamine agonist, has exhibited promising behavioral effects and safety of use in small-sample pilot studies. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanz, Leandro R. D., Lejeune, Nicolas, Blandiaux, Séverine, Bonin, Estelle, Thibaut, Aurore, Stender, Johan, Farber, Neal M., Zafonte, Ross D., Schiff, Nicholas D., Laureys, Steven, Gosseries, Olivia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433751/
https://www.ncbi.nlm.nih.gov/pubmed/30941094
http://dx.doi.org/10.3389/fneur.2019.00248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433751/
https://www.ncbi.nlm.nih.gov/pubmed/30941094
http://dx.doi.org/10.3389/fneur.2019.00248

Ejemplares similares